Vazkepa is a medicine for reducing the risk of cardiovascular events such as heart attack, stroke and other problems caused by blocked blood circulation. It is for use as add-on treatment in adults being treated with a statin medicine who have high levels of triglycerides (a type of fat) in their blood. Vazkepa is to be used in patients either with a cardiovascular disease (a condition that affects the heart or circulation) or with diabetes and another condition that increases the risk of cardiovascular events. Vazkepa contains the active substance icosapent ethyl.
Therapeutic Indication
### Therapeutic indication Indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Therapeutic Area (MeSH)
ATC Code
C10AX
ATC Item
其它血脂调节剂
Pharmacotherapeutic Group
Lipid modifying agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Icosapent ethyl | N/A | 二十碳五烯酸乙酯 |
EMA Name
Vazkepa
Medicine Name
Vazkepa
Aliases
N/A
